Healthcare remains a cornerstone of many long-term portfolios, offering a mix of defensive stability and growth potential through innovation.
Investors must decide whether to cast a wide net across the entire sector with a fund like the Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) or zoom in on the specific economics of drug manufacturing with an investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)
This comparison examines how these two approaches differ in cost, volatility, and dividend performance. Snapshot (cost & size) Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months.
Dividend yield is the trailing-12-month distribution yield. FHLC is significantly more affordable with an expense ratio of 0.08% compared to 0.36% for PPH. However, PPH has offered a higher payout, with a trailing-12-month dividend yield of 2.10% versus 1.40% for the Fidelity fund.